The findings from the PROSPERO study reveal that multiple hospitalizations, long-term disease duration, prior surgeries, and factors like corticosteroid use and total parenteral nutrition ...

Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a biotechnology company pioneering the development of novel therapeutics targeting tumor necrosis factor (TNF) superfamily receptors for the treatment of ...

Wadlington Jr. is competing in A Touch of Football Tournament, an annual fundraising event hosted by the Michigan Chapter of ...

It may not be something you like to talk about, but if you have gastrointestinal (GI) problems, your symptoms may be far more ...

Microscopic colitis, a form of inflammatory bowel disease, has no cure, but it's possible to enter remission. Learn more here ...

An international study led by the University of Oulu and Oulu University Hospital has identified six genetic regions ...

Ulcerative colitis affects daily life, but proper management can help maintain quality of life. Learn how to cope with this ...

Women aged 18 to 45 years with IBD were invited to complete a survey regarding knowledge, attitude, and beliefs about contraception.

A new test developed in the UK can accurately predict whether high-risk patients will develop bowel cancer, also known as ...

Baseline histologic activity predicted colectomy risk in ulcerative colitis treated with biologics, independent of clinical or endoscopic factors.

The recent U.S. Food and Drug Administration approval for Eli Lilly and Co.'s Omvoh, a new therapy to treat Chron's disease ...